Clinical Trial Update: Repetitive Magnetic Transcranial Stimulation (rTMS) in the Treatment of Generalized Anxiety Disorder (GAD) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating repetitive magnetic transcranial stimulation for generalized anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Repetitive Magnetic Transcranial Stimulation (rTMS)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED